Cascadian Therapeutics Inc. (CASC): Billionaire Seth Klarman’s Baupost Group Reports New Stake

Page 5 of 5 – SEC Filing

SIGNATURE

After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and correct.

	The Baupost Group, L.L.C.
Date: July 08, 2016	By:	/s/ Seth A. Klarman
		Name: Seth A. Klarman
		Title: Chief Executive Officer and President

	SAK Corporation
Date: July 08, 2016	By:	/s/ Seth A. Klarman
		Name: Seth A. Klarman
		Title: President

	Seth A. Klarman
Date: July 08, 2016	By:	/s/ Seth A. Klarman
		Name: Seth A. Klarman

Footnotes:

Item 3, Item 4 and Item 7 This statement on Schedule 13G is being jointly filed by The Baupost Group, L.L.C. (“Baupost”), SAK Corporation and Seth A. Klarman. Baupost is a registered investment adviser and acts as an investment adviser and general partner to various private investment limited partnerships. Securities reported on this statement on Schedule 13G as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships. SAK Corporation, as the Manager of Baupost, and Mr. Klarman, as the sole shareholder of SAK Corporation and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Pursuant to Rule 13d-4, Seth A. Klarman and SAK Corporation declare that the filing of this statement on Schedule 13G shall not be deemed an admission by either or both of them that they are, for the purposes of Section 13 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this statement on Schedule 13G.

Attention:

Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)

 

---